These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7718965)

  • 21. Guillain Barre syndrome following acute infective hepatitis.
    Tandon R; Garg MC; Bajpai HS; Agrawal JK
    J Assoc Physicians India; 1986 Jun; 34(6):444-5. PubMed ID: 3771488
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea.
    Park YS; Lee KJ; Kim SW; Kim KM; Suh BC
    J Korean Med Sci; 2017 Jul; 32(7):1154-1159. PubMed ID: 28581273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe dysautonomic onset of Guillain-Barré syndrome with good recovery. A clinical and autonomic follow-up study.
    Cortelli P; Contin M; Lugaresi A; Baruzzi A; Montagna P
    Ital J Neurol Sci; 1990 Apr; 11(2):159-62. PubMed ID: 2361852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Brucellosis and acute inflammatory polyradiculoneuropathy].
    García T; Sánchez JC; Maestre JF; Guisado F; Vilches RM; Morales B
    Neurologia; 1989 May; 4(4):145-7. PubMed ID: 2627488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease.
    Nadkarni N; Lisak RP
    Neurology; 1993 Apr; 43(4):842-3. PubMed ID: 8469352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré syndrome in patients with a recent history of Zika in Cúcuta, Colombia: A descriptive case series of 19 patients from December 2015 to March 2016.
    Arias A; Torres-Tobar L; Hernández G; Paipilla D; Palacios E; Torres Y; Duran J; Ugarte U S; Ardila-Sierra A; Castellanos G
    J Crit Care; 2017 Feb; 37():19-23. PubMed ID: 27610587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of Guillain-Barré syndrome developed minimal change nephrotic syndrome simultaneously.
    Kitamura H; Nakano T; Kakihara M; Nishino M; Isshiki K; Kawano K; Yamauchi A; Imai E; Kamada T; Abe H
    Am J Nephrol; 1998; 18(2):151-4. PubMed ID: 9569959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Facial diplegia as unusual variant of Guillain-Barré syndrome: first case reported in Venezuela].
    Félix Piñerúa-Gonsálvez J; del Carmen Zambrano-Infantino R; Neomar Higuera S; Rodríguez C; Calcaño C
    Invest Clin; 2015 Dec; 56(4):406-10. PubMed ID: 29938969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fulminant guillain-barré syndrome mimicking cerebral death following acute viral hepatitis a.
    Kang BH; Kim KK
    J Clin Neurol; 2007 Jun; 3(2):105-7. PubMed ID: 19513301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe viral hepatitis A infection, Landry-Guillain-Barré syndrome, and hereditary elliptocytosis.
    Grover B; Dalessandro L; Sanders JG; Walter MH; O'Meara TF; Redmond J
    South Med J; 1986 Feb; 79(2):251-2. PubMed ID: 3945858
    [No Abstract]   [Full Text] [Related]  

  • 31. A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy.
    Ji SB; Lee SS; Jung HC; Kim HJ; Kim HJ; Kim TH; Jung WT; Lee OJ; Song DH
    Clin Mol Hepatol; 2016 Sep; 22(3):396-399. PubMed ID: 27572076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
    Verma R; Chaudhari TS; Raut TP; Garg RK
    J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guillain-Barré syndrome associated to a type B acute hepatitis (author's transl)].
    Martí-Massó JF; Obeso JA; Cosme A; de la Fuente E; Carrera N; Figols J
    Med Clin (Barc); 1979 Dec; 73(10):447-50. PubMed ID: 529867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
    Nomura K
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C.
    Boccia F; Florio LL; Durante-Mangoni E; Zampino R
    J Neurovirol; 2023 Oct; 29(5):640-643. PubMed ID: 37646952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [No association between IgG anti-GTla antibody and bulbar palsy in Guillain-Barré and Fisher's syndromes].
    Koga M; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Nov; 37(11):1024-6. PubMed ID: 9503976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pain in Guillain-Barré syndrome.
    Ropper AH; Shahani BT
    Arch Neurol; 1984 May; 41(5):511-4. PubMed ID: 6721720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autonomic involvement in Guillain-Barré syndrome: a review.
    Zochodne DW
    Muscle Nerve; 1994 Oct; 17(10):1145-55. PubMed ID: 7935521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré syndrome associated with Japanese encephalitis virus infection in China.
    Xiang JY; Zhang YH; Tan ZR; Huang J; Zhao YW
    Viral Immunol; 2014 Oct; 27(8):418-20. PubMed ID: 25140441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia.
    Blum S; Reddel S; Spies J; McCombe P
    J Peripher Nerv Syst; 2013 Dec; 18(4):316-20. PubMed ID: 24172315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.